Cetilar

PharmaNutra is an Italian pharmaceutical and nutraceutical company founded in 2003, primarily known for its innovative Cetilar and SiderAL product lines. The company specializes in the development of medical devices and nutritional supplements, utilizing proprietary technologies to enhance nutrient absorption and therapeutic efficacy. Its flagship brand, Cetilar, focuses on musculoskeletal health through the use of cetylated fatty acids (CFA) to treat joint and muscle pain. PharmaNutra also pioneered Sucrosomial Technology, a proprietary delivery system used to improve the absorption and tolerability of minerals like iron. The company is publicly traded on the Borsa Italiana and maintains a strong presence in sports medicine through extensive clinical research and high-profile sponsorships.